Maternal and Infant Outcomes Among Pregnant Women Treated for Multidrug/Rifampicin-Resistant Tuberculosis in South Africa

BACKGROUND: Data on safety and efficacy of second-line tuberculosis drugs in pregnant women and their infants are severely limited due to exclusion from clinical trials and expanded access programs. METHODS: Pregnant women starting treatment for multidrug/rifampicin-resistant (MDR/RR)-tuberculosis a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Loveday, Marian, Hughes, Jennifer, Sunkari, Babu, Master, Iqbal, Hlangu, Sindisiwe, Reddy, Tarylee, Chotoo, Sunitha, Green, Nathan, Seddon, James A
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Major Articles and Commentaries
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8028100/
https://ncbi.nlm.nih.gov/pubmed/32141495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa189
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados